Type 2 Diabetes

The US Food and Drug Administration has approved Jentadueto, a type 2 diabetes treatment that combines two drugs (linagliptin and metformin) in a single pill.

Consumption of sugar, which helps to drive the obesity crisis and causes millions of deaths worldwide each year, should be controlled like other threats to public health, a team of researchers from the University of California San Francisco argue in the Feb. 2 issue of Nature.

Poor sleep is connected to a significantly increased risk for major cardiovascular and metabolic disorders, such as obesity, diabetes, and coronary artery disease, researchers at the University of Pennsylvania's Perelman School of Medicine have found.

According to a study by the National Institute of Environmental Health Sciences (NIEHS), more than 32 million people in the United States have proteins created by the immune system that target the body's tissues. Known as autoantibodies, these proteins are typically markers for autoimmunity, which can result in conditions such as type 1 diabetes and rheumatoid arthritis.

The US Food and Drug Administration has approved Amylin Pharmaceuticals Inc.'s Bydureon as the first once-weekly treatment for type 2 diabetes after several years of delays due to concerns over the drug's safety.

Regular monthly contact with a nurse increases the quality of life for patients with diabetes or hypertension, a recent study has found.

Paula Deen confirmed on Tuesday that she does in fact have type 2 diabetes, a diagnosis she has kept a secret for three years.

A meta-analysis of several dozen studies has found that lifestyle intervention programs for those at high risk of diabetes resulted in moderate weight loss regardless of whether they were facilitated by high-cost clinically trained professionals or lower-cost lay educators.

A novel treatment method called stem cell educator therapy appears to reverse the effects of type 1 diabetes, researchers at the University of Illinois at Chicago and colleagues in China report.

Postmenopausal women who are taking statins appear to have an increased risk of developing diabetes, researchers have found.

The best setting for the treatment of painful diabetic neuropathy is primary care, where diabetes and its associated chronic pain can be managed as a single entity. The American Diabetes Association defines diabetic peripheral neuropathy (DPN) as "the presence of symptoms and/or signs of peripheral nerve dysfunction in patients with diabetes after exclusion of other causes." Approximately 16% of diabetic patients will experience painful diabetic neuropathy (PDN).

Children born to mothers who are of low socioeconomic status or have maternal gestational diabetes mellitus may be at increased risk of developing ADHD.

Adolescents with type 1 diabetes may have difficulty getting a full night of sleep, which can greatly impact their performance in school and, worse, their blood sugar control, researchers at the University of Arizona have found.

Promising initial results from a Phase 3 trial of DiaPep277 have raised hopes that an alternative to insulin may soon be available to treat type 1 diabetes.

Amidst smartphone applications that transform your thumbs into drumsticks and others that make "whoosh" noises as you swing around your phone/digital lightsaber, there are apps that can actually be quite useful in the medical field.

According to a recent report from the NHS Information Centre, roughly 24,000 diabetes-related deaths that occur each year can be prevented by better management of the condition on the parts of both patients and doctors.

In a move that has been long anticipated by the diabetes community, the FDA has finally issued a draft guidance designed to aid investigators and manufacturers seeking approval for and developing "artificial pancreas" devices.

According to a nationwide review of data from the in-patient register, 31 of the 33 autoimmune diseases studied were associated with an increased risk of pulmonary embolism (a blood clot on the lung), including type 1 diabetes.

According to a study performed at the Chonnam National University Medical School in Gwangju, Korea, diabetes mellitus may be an independent predictor of disease recurrence and progression in patients who suffer from non-muscle invasive bladder cancer.

According to a recent study, type 1 diabetes sufferers who receive early and intensive diabetes management may be able to cut their risk of impaired glomerular filtration rate (GFR), a kidney complication common to diabetics, by 50%.

According to a report issued by the International Diabetes Federation (IDF), diabetes is predicted to rise substantially by the year 2030, to the point where one in 10 adults will suffer from the condition. Should this prediction come to pass, roughly 552 million people will have diabetes within twenty years.

In an effort to hurry along the FDA approval process for the artificial pancreas, members of the Juvenile Diabetes Research Foundation, government officials, health care professionals, and a large number of type 1 diabetics congregated in Washington, DC.

According to a report in the August 2009 issue of Diabetes Care, even when patients with type 1 diabetes have excellent hemoglobin A1C levels, continuous glucose monitoring will be beneficial.

In honor of Diabetes Awareness Month, the ADA put together video clips of health care professionals pledging to stop diabetes.

A new study by Japanese researchers may support transplanting neural stems cells into a patient's pancreas as a viable treatment for type 1 diabetes.

Scientists at Stanford University have identified a pathway responsible for age-related beta cell decline.

Patients with type 1 diabetes who experience hyperglycemia or severe hypoglycemia in their youth are at risk of impaired brain development, a new study finds.

The largest ever genome-wide association study of those with type 1 diabetes has discovered three new genetic anomalies associated with the disease.

New research has found evidence confirming that patients with diabetes have a higher risk of developing colon cancer.

Men are more prone to developing type 2 diabetes at a lower BMI than women.